Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
12 June 2018
Corporate presentations
REVERSE Phase III trial of GS010 – KOL Breakfast
Open in new window
27 April 2018
General meetings
Results of the votes
Open in new window
27 April 2018
General meetings
Attendance sheet
Open in new window
27 April 2018
Financial statements and reports
2017 Registration Document
Open in new window
22 March 2018
General meetings
Notice of General Meeting on April 12, 2018
Open in new window
22 March 2018
General meetings
Nominees to directorship
Open in new window
22 March 2018
General meetings
Proxy Card
Open in new window
22 March 2018
General meetings
Supplementary report of the Board on the issuance of ordinary shares on June 22, 2017
Open in new window
22 March 2018
General meetings
Report of auditors on 2017 financial statements in accordance with French GAAP
Open in new window
22 March 2018
General meetings
Report of auditors on 2017 consolidated financial statements in accordance with IFRS
Open in new window
View previous 9 articles
1
…
12
13
14
15
16
17
18
19
20
21
View next 9 articles
Go back to the page of the page